Bellerophon Therapeutics Inc
NASDAQ:BLPH
Income Statement
Earnings Waterfall
Bellerophon Therapeutics Inc
Revenue
|
5.6m
USD
|
Operating Expenses
|
-19.6m
USD
|
Operating Income
|
-14m
USD
|
Other Expenses
|
1.6m
USD
|
Net Income
|
-12.4m
USD
|
Income Statement
Bellerophon Therapeutics Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
6
N/A
|
6
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(48)
|
(64)
|
(60)
|
(59)
|
(54)
|
(50)
|
(48)
|
(41)
|
(35)
|
(27)
|
(24)
|
(21)
|
(23)
|
(25)
|
(25)
|
(28)
|
(30)
|
(31)
|
(28)
|
(24)
|
(20)
|
(18)
|
(17)
|
(17)
|
(19)
|
(22)
|
(26)
|
(28)
|
(27)
|
(24)
|
(20)
|
(20)
|
(21)
|
(22)
|
(22)
|
(21)
|
(20)
|
|
Selling, General & Administrative |
(10)
|
(13)
|
(14)
|
(16)
|
(15)
|
(16)
|
(15)
|
(12)
|
(10)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(9)
|
(8)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
|
Research & Development |
(39)
|
(50)
|
(46)
|
(43)
|
(39)
|
(35)
|
(33)
|
(29)
|
(24)
|
(20)
|
(17)
|
(15)
|
(16)
|
(18)
|
(18)
|
(21)
|
(22)
|
(23)
|
(20)
|
(16)
|
(13)
|
(11)
|
(11)
|
(11)
|
(12)
|
(15)
|
(18)
|
(19)
|
(19)
|
(16)
|
(13)
|
(14)
|
(15)
|
(16)
|
(16)
|
(15)
|
(13)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(48)
N/A
|
(64)
-32%
|
(60)
+6%
|
(59)
+1%
|
(54)
+9%
|
(50)
+7%
|
(48)
+4%
|
(41)
+15%
|
(35)
+16%
|
(27)
+21%
|
(24)
+13%
|
(21)
+10%
|
(23)
-5%
|
(25)
-9%
|
(25)
0%
|
(28)
-15%
|
(30)
-5%
|
(31)
-2%
|
(28)
+9%
|
(24)
+15%
|
(20)
+15%
|
(18)
+11%
|
(17)
+2%
|
(17)
+1%
|
(19)
-9%
|
(22)
-20%
|
(26)
-17%
|
(28)
-7%
|
(27)
+2%
|
(24)
+13%
|
(20)
+16%
|
(20)
+1%
|
(21)
-7%
|
(22)
-1%
|
(22)
-4%
|
(15)
+32%
|
(14)
+8%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(15)
|
(13)
|
(14)
|
(30)
|
(9)
|
(15)
|
5
|
25
|
20
|
24
|
7
|
3
|
0
|
(1)
|
(0)
|
(1)
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(48)
N/A
|
(64)
-32%
|
(60)
+6%
|
(58)
+3%
|
(53)
+9%
|
(48)
+8%
|
(46)
+4%
|
(41)
+13%
|
(34)
+16%
|
(27)
+20%
|
(24)
+11%
|
(36)
-50%
|
(35)
+3%
|
(39)
-10%
|
(55)
-42%
|
(37)
+32%
|
(45)
-20%
|
(26)
+42%
|
(3)
+90%
|
(4)
-48%
|
3
N/A
|
(12)
N/A
|
(15)
-27%
|
(17)
-16%
|
(19)
-11%
|
(23)
-19%
|
(27)
-17%
|
(27)
-2%
|
(27)
+3%
|
(23)
+12%
|
(20)
+16%
|
(20)
-1%
|
(21)
-7%
|
(22)
-2%
|
(22)
-3%
|
(15)
+32%
|
(14)
+9%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
0
|
2
|
2
|
2
|
4
|
1
|
|
Income from Continuing Operations |
(48)
|
(64)
|
(60)
|
(58)
|
(53)
|
(48)
|
(46)
|
(41)
|
(34)
|
(27)
|
(24)
|
(36)
|
(35)
|
(38)
|
(55)
|
(32)
|
(39)
|
(20)
|
3
|
(2)
|
5
|
(10)
|
(13)
|
(17)
|
(17)
|
(21)
|
(25)
|
(25)
|
(25)
|
(21)
|
(18)
|
(18)
|
(19)
|
(19)
|
(20)
|
(11)
|
(12)
|
|
Net Income (Common) |
(48)
N/A
|
(64)
-32%
|
(60)
+6%
|
(58)
+3%
|
(53)
+9%
|
(48)
+8%
|
(46)
+4%
|
(41)
+13%
|
(34)
+16%
|
(27)
+20%
|
(24)
+13%
|
(36)
-51%
|
(35)
+3%
|
(38)
-10%
|
(55)
-44%
|
(32)
+42%
|
(39)
-24%
|
(20)
+48%
|
3
N/A
|
(2)
N/A
|
5
N/A
|
(10)
N/A
|
(13)
-31%
|
(17)
-31%
|
(17)
+2%
|
(21)
-21%
|
(25)
-19%
|
(25)
-2%
|
(25)
+2%
|
(21)
+13%
|
(18)
+17%
|
(18)
-1%
|
(19)
-4%
|
(19)
-2%
|
(20)
-4%
|
(11)
+43%
|
(12)
-9%
|
|
EPS (Diluted) |
-61.02
N/A
|
-120.16
-97%
|
-75.53
+37%
|
-85.41
-13%
|
-61.32
+28%
|
-56.27
+8%
|
-56.65
-1%
|
-46.67
+18%
|
-39.27
+16%
|
-29.59
+25%
|
-23.81
+20%
|
-16.85
+29%
|
-15.48
+8%
|
-16.34
-6%
|
-21.08
-29%
|
-6.56
+69%
|
-10.24
-56%
|
-4.75
+54%
|
0.65
N/A
|
-0.47
N/A
|
1.16
N/A
|
-2.22
N/A
|
-2.95
-33%
|
-3.77
-28%
|
-2.27
+40%
|
-2.19
+4%
|
-3.17
-45%
|
-2.65
+16%
|
-2.62
+1%
|
-2.26
+14%
|
-1.87
+17%
|
-1.88
-1%
|
-1.96
-4%
|
-2
-2%
|
-2.08
-4%
|
-1.07
+49%
|
-1.01
+6%
|